Adagene Inc. 6-K Filing

From the Filing

EDGAR Filing Documents for 0001104659-26-038618 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001104659-26-038618 Filing Date 2026-04-01 Accepted 2026-04-01 17:16:24 Documents 3 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 FORM 6-K tm2527488d2_6k.htm 6-K 11406 2 EXHIBIT 99.1 tm2527488d2_ex99-1.htm EX-99.1 153637 3 GRAPHIC tm2527488d2_ex99-1img001.jpg GRAPHIC 3248 Complete submission text file 0001104659-26-038618.txt 170803 Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632 Adagene Inc. (Filer) CIK : 0001818838 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-39997 | Film No.: 26829446 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)